Search research articles
Contact Us
Filters
Showing results (631-640 of 706) with videos related to
Page
of 71
Sort By:
BMC Medical Genomics
|
February 2, 2019
Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma
Lijun Cheng, Pankita H Pandya, Enze Liu, et al.
Breast Cancer Research and Treatment
|
January 21, 2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort
N Lynn Henry, James M Rae, Lang Li, et al.
Plos One
|
May 31, 2024
Dynamic natural components and morphological changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome and mild chronic kidney disease at the 1-year follow-up and clinical significance at the 5-year follow-up
Jia-Cong Nong, Wei You, Yi-Fei Wang, et al.
Clinical Pharmacology and Therapeutics
|
July 4, 2006
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment
Silvana Borges, Zeruesenay Desta, Lang Li, et al.
Bioinformatics (Oxford, England)
|
July 1, 2006
A mixture model-based discriminate analysis for identifying ordered transcription factor binding site pairs in gene promoters directly regulated by estrogen receptor-alpha
Lang Li, Alfred S L Cheng, Victor X Jin, et al.
Cancer Research
|
December 21, 2006
Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant
Meiyun Fan, Pearlly S Yan, Cori Hartman-Frey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2011
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia
Rajasubramaniam Shanmugam, Padmaja Gade, Annique Wilson-Weekes, et al.
Science Advances
|
January 17, 2025
Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk
Lang Li, Hao Tian, Liulin Wu, et al.
Oncogene
|
August 29, 2022
GSTM2 is a key molecular determinant of resistance to SG-ARIs
Chaohao Li, Jinpeng Liu, Daheng He, et al.
Pharmacogenomics
|
March 19, 2010
Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research Network
Elizabeth J Atkinson, Shannon K McDonnell, John S Witte, et al.
Page
of 71
Search research articles
Search
Showing results (631-640 of 706) with videos related to
Sort By:
Page
of 71
BMC Medical Genomics
|
February 2, 2019
Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma
Lijun Cheng, Pankita H Pandya, Enze Liu, et al.
Breast Cancer Research and Treatment
|
January 21, 2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort
N Lynn Henry, James M Rae, Lang Li, et al.
Plos One
|
May 31, 2024
Dynamic natural components and morphological changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome and mild chronic kidney disease at the 1-year follow-up and clinical significance at the 5-year follow-up
Jia-Cong Nong, Wei You, Yi-Fei Wang, et al.
Clinical Pharmacology and Therapeutics
|
July 4, 2006
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment
Silvana Borges, Zeruesenay Desta, Lang Li, et al.
Bioinformatics (Oxford, England)
|
July 1, 2006
A mixture model-based discriminate analysis for identifying ordered transcription factor binding site pairs in gene promoters directly regulated by estrogen receptor-alpha
Lang Li, Alfred S L Cheng, Victor X Jin, et al.
Cancer Research
|
December 21, 2006
Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant
Meiyun Fan, Pearlly S Yan, Cori Hartman-Frey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2011
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia
Rajasubramaniam Shanmugam, Padmaja Gade, Annique Wilson-Weekes, et al.
Science Advances
|
January 17, 2025
Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk
Lang Li, Hao Tian, Liulin Wu, et al.
Oncogene
|
August 29, 2022
GSTM2 is a key molecular determinant of resistance to SG-ARIs
Chaohao Li, Jinpeng Liu, Daheng He, et al.
Pharmacogenomics
|
March 19, 2010
Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research Network
Elizabeth J Atkinson, Shannon K McDonnell, John S Witte, et al.
Page
of 71